Patents by Inventor Scheffer Tseng

Scheffer Tseng has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9682160
    Abstract: Disclosed herein, are methods of preparing sterilized amniotic tissues. Further disclosed herein, are methods of using the sterilized amniotic tissues.
    Type: Grant
    Filed: August 5, 2015
    Date of Patent: June 20, 2017
    Assignee: TISSUETECH, INC.
    Inventors: Scheffer Tseng, Ek Kia Tan
  • Patent number: 9682044
    Abstract: Disclosed herein, are methods of preparing fetal support tissue powders. Further disclosed herein, are methods of using the fetal support tissue powder product.
    Type: Grant
    Filed: June 8, 2012
    Date of Patent: June 20, 2017
    Assignee: TISSUETECH, INC.
    Inventors: Scheffer Tseng, Ek Kia Tan, Lorraine Chua
  • Patent number: 9675733
    Abstract: Disclosed herein, in certain instances, are methods of inhibiting osteoclast differentiation, bone resorption, bone formation, and bone remodeling in an individual in need thereof, comprising administering to the individual a composition comprising substantially fetal support tissue product including amniotic membrane and umbilical cord or an extract thereof, or a composition comprising substantially isolated HC-HA complex.
    Type: Grant
    Filed: November 10, 2016
    Date of Patent: June 13, 2017
    Assignee: TISSUETECH, INC.
    Inventors: Scheffer Tseng, Ek Kia Tan, Hua He
  • Publication number: 20170072102
    Abstract: Disclosed herein, in certain instances, are methods of inhibiting osteoclast differentiation, bone resorption, bone formation, and bone remodeling in an individual in need thereof, comprising administering to the individual a composition comprising substantially fetal support tissue product including amniotic membrane and umbilical cord or an extract thereof, or a composition comprising substantially isolated HC-HA complex.
    Type: Application
    Filed: November 10, 2016
    Publication date: March 16, 2017
    Inventors: Scheffer TSENG, Ek Kia TAN, Hua HE
  • Publication number: 20160376305
    Abstract: Provided herein are methods for the production of native and reconstituted hyaluronan (HA) complexes containing pentraxin-3 (PTX3) and heavy chain 1 (HC1) of inter alpha inhibitor (I?I). Compositions containing the complexes and therapeutic methods using the complexes are provided. Combinations and kits for use in practicing the methods also are provided.
    Type: Application
    Filed: July 20, 2016
    Publication date: December 29, 2016
    Inventors: Scheffer TSENG, Hua HE, Sean TIGHE, Suzhen ZHANG, Ying-Tieng ZHU
  • Patent number: 9526770
    Abstract: Disclosed herein, in certain instances, are methods of inhibiting osteoclast differentiation, bone resorption, bone formation, and bone remodeling in an individual in need thereof, comprising administering to the individual a composition comprising substantially fetal support tissue product including amniotic membrane and umbilical cord or an extract thereof, or a composition comprising substantially isolated HC-HA complex.
    Type: Grant
    Filed: April 27, 2012
    Date of Patent: December 27, 2016
    Assignee: TISSUETECH, INC.
    Inventors: Scheffer Tseng, Ek Kia Tan, Hua He
  • Publication number: 20160339061
    Abstract: Compositions and preparations of fetal support tissue that prevent or reduce the proliferation and epithelial-mesenchymal transition (EMT) of epithelial cells, wherein the epithelial cells may be human epithelial cells and the human epithelial cells may be conjunctival, retinal, corneal, limbal, or renal epithelial cells. Methods of preventing or reducing the proliferation, cell migration, and EMT of epithelial cells in an individual in need thereof, wherein the epithelial cells may be human epithelial cells and the human epithelial cells may be conjunctival, retinal, corneal, limbal, or renal epithelial cells. Methods of preventing or treating proliferative vitreoretinopathy in an individual in need thereof.
    Type: Application
    Filed: May 20, 2016
    Publication date: November 24, 2016
    Inventors: Scheffer TSENG, Ek Kia TAN, Hua HE
  • Publication number: 20160324902
    Abstract: Disclosed herein, in certain instances, are tissue grafts derived from UCAM. Further disclosed herein, in certain instances, are use for tissue grafts derived from UCAM.
    Type: Application
    Filed: July 20, 2016
    Publication date: November 10, 2016
    Inventors: Scheffer TSENG, Ek Kia TAN, Amy TSENG
  • Publication number: 20160303171
    Abstract: Disclosed herein, in certain instances, are tissue grafts derived from UCAM. Further disclosed herein, in certain instances, are use for tissue grafts derived from UCAM.
    Type: Application
    Filed: June 28, 2016
    Publication date: October 20, 2016
    Inventors: Scheffer TSENG, Ek Kia TAN, Amy TSENG
  • Publication number: 20160243288
    Abstract: The invention relates generally to the fields of biology and health sciences. More particularly, the invention relates to compositions and methods for modulating cellular physiology and pathological processing using a combination of compounds that can be found in amniotic membrane tissue and umbilical cord tissue preparations.
    Type: Application
    Filed: February 23, 2016
    Publication date: August 25, 2016
    Applicant: TissueTech, Inc.
    Inventors: Scheffer TSENG, Ek Kia TAN
  • Publication number: 20160184368
    Abstract: Disclosed herein, in certain instances, are tissue grafts derived from UCAM. Further disclosed herein, in certain instances, are use for tissue grafts derived from UCAM.
    Type: Application
    Filed: January 14, 2016
    Publication date: June 30, 2016
    Inventors: Scheffer TSENG, Ek Kia TAN, Amy TSENG
  • Publication number: 20160151424
    Abstract: Compositions having a combination of specific biological components have been found to exert a number of useful effects in mammalian cells, including modulating TGF ? signaling, apoptosis, and proliferation of mammalian cells, as well as decreasing inflammation in mice. These components can be obtained commercially, or can be prepared from biological tissues such as placental tissues. Placental amniotic membrane (AM) preparations described herein include AM pieces, AM extracts, AM jelly, AM stroma, and mixtures of these compositions with additional components. The compositions can be used to treat various diseases, such as wound healing, inflammation and angiogenesis-related diseases.
    Type: Application
    Filed: September 8, 2015
    Publication date: June 2, 2016
    Inventors: Scheffer TSENG, Hua HE, Wei LI
  • Publication number: 20160129050
    Abstract: Compositions having a combination of specific biological components have been found to exert a number of useful effects in mammalian cells, including modulating TGF ? signaling, apoptosis, and proliferation of mammalian cells, as well as decreasing inflammation in mice. These components can be obtained commercially, or can be prepared from biological tissues such as placental tissues. Placental amniotic membrane (AM) preparations described herein include AM pieces, AM extracts, AM jelly, AM stroma, and mixtures of these compositions with additional components. The compositions can be used to treat various diseases, such as wound healing, inflammation and angiogenesis-related diseases.
    Type: Application
    Filed: September 8, 2015
    Publication date: May 12, 2016
    Inventors: Scheffer TSENG, Hua HE, Wei LI
  • Publication number: 20160129051
    Abstract: Compositions having a combination of specific biological components have been found to exert a number of useful effects in mammalian cells, including modulating TGF ? signaling, apoptosis, and proliferation of mammalian cells, as well as decreasing inflammation in mice. These components can be obtained commercially, or can be prepared from biological tissues such as placental tissues. Placental amniotic membrane (AM) preparations described herein include AM pieces, AM extracts, AM jelly, AM stroma, and mixtures of these compositions with additional components. The compositions can be used to treat various diseases, such as wound healing, inflammation and angiogenesis-related diseases.
    Type: Application
    Filed: October 9, 2015
    Publication date: May 12, 2016
    Inventors: Scheffer TSENG, Hua He, Wei Li
  • Publication number: 20160129049
    Abstract: Compositions having a combination of specific biological components have been found to exert a number of useful effects in mammalian cells, including modulating TGF ? signaling, apoptosis, and proliferation of mammalian cells, as well as decreasing inflammation in mice. These components can be obtained commercially, or can be prepared from biological tissues such as placental tissues. Placental amniotic membrane (AM) preparations described herein include AM pieces, AM extracts, AM jelly, AM stroma, and mixtures of these compositions with additional components. The compositions can be used to treat various diseases, such as wound healing, inflammation and angiogenesis-related diseases.
    Type: Application
    Filed: September 8, 2015
    Publication date: May 12, 2016
    Inventors: Scheffer TSENG, Hua HE, Wei LI
  • Publication number: 20160120912
    Abstract: The invention relates generally to the fields of biology and health sciences. More particularly, the invention relates to compositions and methods for modulating cellular physiology and pathological processing using a combination of compounds that can be found in amniotic membrane tissue and umbilical cord tissue preparations.
    Type: Application
    Filed: November 5, 2015
    Publication date: May 5, 2016
    Inventor: Scheffer TSENG
  • Publication number: 20160106785
    Abstract: Disclosed herein, in certain instances, are tissue grafts derived from UCAM. Further disclosed herein, in certain instances, are use for tissue grafts derived from UCAM.
    Type: Application
    Filed: October 19, 2015
    Publication date: April 21, 2016
    Inventors: Scheffer TSENG, Ek Kia TAN, Amy TSENG
  • Publication number: 20160095931
    Abstract: Disclosed herein, in certain embodiments, is an HC•HA complex comprising hyaluronan and a heavy chain of I?I, wherein the transfer of the heavy chain of I?I is catalyzed by TSG-6. Further disclosed herein, in certain embodiments, is an HC•HA complex comprising hyaluronan and a heavy chain of I?I, wherein the transfer of the heavy chain of I?I is catalyzed by the TSG-6 like protein. Additionally, disclosed herein are methods of manufacturing said complex and methods of use thereof.
    Type: Application
    Filed: September 29, 2015
    Publication date: April 7, 2016
    Inventors: Scheffer TSENG, Hua HE
  • Publication number: 20160008295
    Abstract: The present invention relates to terpine-4-ol containing pharmaceutical compositions, dermatological delivery systems and methods of treatment that are useful for treating rosacea, to include ocular rosacea, papulopustular rosacea, phymatous rosacea, acne rosacea, rosacea associated with Demodex infections, erythematelangiectatic rosacea, steroid induced rosacea, and combinations thereof, acne vulgaris and related conditions in a patient in need thereof.
    Type: Application
    Filed: July 14, 2015
    Publication date: January 14, 2016
    Inventors: Scheffer TSENG, Sean TIGHE
  • Publication number: 20150342998
    Abstract: The invention relates generally to the fields of biology and life sciences. More particularly, the invention relates to compositions and methods for modulating cellular physiology and pathological processing using a combination of compounds that can be found in morselized amniotic membrane tissue and morselized umbilical cord tissue preparations.
    Type: Application
    Filed: June 3, 2015
    Publication date: December 3, 2015
    Inventors: Scheffer TSENG, Lorraine CHUA